Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.
This report contains market size and forecasts of Angiotensin II Receptor Blockers in global, including the following market information:
Global Angiotensin II Receptor Blockers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Angiotensin II Receptor Blockers Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Angiotensin II Receptor Blockers companies in 2021 (%)
The global Angiotensin II Receptor Blockers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Azilsartan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Angiotensin II Receptor Blockers include Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin II Receptor Blockers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin II Receptor Blockers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, by Type, 2021 (%)
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Global Angiotensin II Receptor Blockers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, by Application, 2021 (%)
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Global Angiotensin II Receptor Blockers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Angiotensin II Receptor Blockers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin II Receptor Blockers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Angiotensin II Receptor Blockers revenues share in global market, 2021 (%)
Key companies Angiotensin II Receptor Blockers sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Angiotensin II Receptor Blockers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan